S-1: Mullen Automotive Files for Resale of 20 Million Shares Amid Convertible Note and Warrant Issuance

Sentiment:

S-1 Filing


Mullen Automotive is registering for resale up to 20 million shares of its common stock, potentially impacting current shareholders.

Capital raiseThe company entered into a securities purchase agreement on May 14, 2024, with investors to sell $52.6 million in convertible notes and warrants.The investors purchased an initial aggregate principal amount of $13.2 million, or $12.5 million including the 5% original issue discount, of Notes and also received Warrants, and are obligated to purchase an additional principal amount of $39.5 million, or $37.5 million including the 5% original issue discount, of Notes and related Warrants if certain conditions are satisfied.For a period beginning on May 14, 2024 and ending on the one year anniversary from the later of (i) the date a registration statement registering the shares issuable upon conversion of the Notes and exercise of the Warrants is declared effective or (ii) the date the Company has obtained stockholder approval for the transaction, the investors have the right, but not the obligation, to purchase an additional $52.6 million of 5% Original Issue Discount Senior Secured Convertible Notes and related Warrants on the same terms and conditions.
Worse than expectedThe potential dilution of existing shares due to the resale of 20 million shares is worse than expected.

Summary

  • Mullen Automotive has filed a registration statement for the resale of up to 20,000,000 shares of common stock.
  • These shares are issuable upon the conversion of convertible notes and the exercise of warrants previously issued by the company.
  • The registration covers additional shares that may be issued under anti-dilution provisions in the notes and warrants.
  • The selling stockholders, who acquired the notes and warrants, may offer these shares from time to time.
  • Mullen Automotive will not receive any proceeds from the sale of these shares by the selling stockholders, except from potential cash exercises of the warrants.
  • The company's common stock is listed on the Nasdaq Capital Market under the symbol MULN, with a last reported sale price of $4.86 per share on May 17, 2024.
  • The company is considered a smaller reporting company and is subject to reduced public company reporting requirements.
  • The company entered into a securities purchase agreement on May 14, 2024, with investors to sell $52.6 million in convertible notes and warrants.
  • The notes accrue interest at 15% per annum and have a 5% original issue discount, maturing in four months.
  • The conversion price of the notes is the lower of $5.49, 95% of the closing sale price on the registration statement's effective date, or 95% of the lowest daily volume-weighted average price in the five trading days prior to conversion, but not less than $1.16 per share.
  • The warrants are exercisable for 200% of the shares underlying the notes at an exercise price equal to 105% of the closing sale price on the execution date.
  • The company may require the warrant holders to exercise the warrants for cash if the stock price increases 250% from the conversion price for 10 consecutive days and other conditions are met.
  • The notes and warrants are not convertible if the holder would own more than 9.9% of the common stock or if the aggregate number of shares issued exceeds 19.9% of the outstanding shares, unless stockholder approval is obtained.
  • The company intends to seek stockholder approval at a special meeting.
  • The company has agreed to file the registration statement within five days and use reasonable efforts to have it declared effective within 45 days, or face penalties.
  • The company is subject to a lock-up period, restricting its ability to issue additional equity securities.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the potential dilution and downward pressure on the stock price from the resale of shares, despite the potential for capital infusion from warrant exercises.

Positives

  • The company has the option to force warrant holders to exercise their warrants for cash under certain conditions, which could provide the company with additional capital.
  • The company is actively seeking stockholder approval to remove conversion limits on the notes and warrants, which could simplify the capital structure.

Negatives

  • The resale of a large number of shares by selling stockholders could put downward pressure on the stock price.
  • The conversion of preferred stock and the exercise of warrants will dilute existing shareholders' ownership.
  • The company is subject to a lock-up period, restricting its ability to raise additional capital through equity offerings.
  • The company faces potential penalties for delays in the registration process.
  • The notes are secured by a continuing security interest in all of the company's assets, which could limit financial flexibility.

Risks

  • The selling stockholders may sell a large number of shares, resulting in substantial diminution to the value of shares of Common Stock held by our current stockholders.
  • The market price of shares of our Common Stock could decline as a result of substantial sales of our Common Stock, particularly sales by our directors, executive officers and significant stockholders.
  • Our outstanding shares of convertible preferred stock contain anti-dilution protection, which may cause significant dilution to our stockholders.
  • Our commitments to issue shares of Common Stock or securities that are convertible into shares of Common Stock may cause significant dilution to our stockholders.
  • Our commitment to issue shares of Common Stock pursuant to the terms of the Notes, our preferred stock and Warrants could encourage short sales by third parties, which could contribute to the future decline of our stock price.
  • Pursuant to the terms of the Securities Purchase Agreement, the Company may not be able to sell securities in order to obtain additional financing, which could force us to delay, limit, reduce or terminate our product development efforts or other operations.

Future Outlook

The company intends to seek stockholder approval to remove conversion limits on the notes and warrants. The selling stockholders may sell all, some or none of their shares in this offering.

Industry Context

The document mentions a significant transformation in the motor vehicle landscape with electric vehicles becoming mainstream and major OEMs investing billions in electric propulsion. Mullen believes it is at the forefront of this transformation, leading the way in commercial trucks.

Stakeholder Impact

  • Shareholders may experience dilution and potential downward pressure on the stock price.
  • Employees may be affected by the company's ability to execute its business plan, which is dependent on securing financing.
  • Customers and suppliers may be impacted by the company's financial stability and ability to deliver products and services.

Next Steps

  • The company intends to seek stockholder approval to remove conversion limits on the notes and warrants.
  • The company must file the registration statement within five days and use reasonable efforts to have it declared effective within 45 days.

Key Dates

DateDescription
April 20, 2010The Company was originally formed as a developer and manufacturer of electric vehicle technology.
November 5, 2021The Company completed a reverse merger transaction with Net Element, Inc., which changed its name to Mullen Automotive Inc.
May 1, 2024The Board of Directors of the Company declared a dividend distribution of one right for each outstanding share of Common Stock and Preferred Stock.
May 13, 2024Record date for the dividend distribution of rights.
May 14, 2024The Company entered into a securities purchase agreement with certain investors.
May 17, 2024The last reported sale price of our common stock on The Nasdaq Capital Market was $4.86 per share.
May 20, 2024Date of the prospectus.

Keywords

Mullen Automotive, common stock, convertible notes, warrants, resale, securities purchase agreement, dilution, registration statement, selling stockholders, financing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.